Oracle Corporation
ORCL
$188.33
-2.24%
Oracle Corporation is a global technology leader providing enterprise software, database management systems, cloud infrastructure, and hardware solutions, operating within the Software - Infrastructure industry. The company is a dominant player in enterprise database software and a significant competitor in the cloud infrastructure market, leveraging its legacy customer base to drive its transition to a cloud-first platform company. The current investor narrative is intensely focused on Oracle's massive capital investment plans to capture AI infrastructure demand, as evidenced by recent news highlighting a massive backlog and investor concerns over the significant cash burn required to fund this growth, creating a debate between long-term opportunity and near-term financial strain.…
ORCL
Oracle Corporation
$188.33
Related headlines
Investment Opinion: Should I buy ORCL Today?
Rating: Hold. The core thesis is that Oracle presents a high-risk, high-reward proposition where massive AI-driven future growth is currently overshadowed by severe near-term financial strain, making the stock suitable only for risk-tolerant investors with a long time horizon.
Supporting evidence includes the compelling 21.66% YoY revenue growth and $638B backlog, but these are counterbalanced by alarming financial metrics: negative FCF of -$24.74B, a high D/E of 3.63, and volatile margins. The forward P/E of 16.94x and PEG of 1.26 suggest the market has priced in a significant earnings recovery, but the elevated trailing P/E of 41.80x offers little margin of safety. Analyst sentiment is unanimously bullish, but the stock's -30.73% relative underperformance versus the S&P 500 indicates the market remains deeply skeptical.
The two biggest risks are prolonged negative free cash flow eroding balance sheet health, and failure to meet the lofty earnings growth implied by the forward P/E. This Hold rating would upgrade to a Buy if quarterly FCF turns positive, signaling capex discipline and a path to self-funding growth, or if the stock sustains a break above the $248 resistance level on high volume. It would downgrade to a Sell if debt-to-equity rises above 4.0 or if revenue growth decelerates below 15% YoY. Relative to its own history and growth profile, the stock appears fairly valued at current levels, with the premium pricing future success that is far from guaranteed.
Sign up to view all
ORCL 12-Month Price Forecast
Oracle is a bifurcated story where powerful growth drivers collide with severe financial headwinds. The 21.7% revenue growth and massive backlog justify a premium, but the -$24.7B FCF and high leverage create tangible risk of dilution or financial stress. The neutral stance reflects this standoff; the stock is not cheap enough to ignore the risks, nor is the growth story compelling enough to overlook the cash burn. Confidence is medium due to high earnings volatility and macro sensitivity (beta 1.655). The stance would upgrade to bullish on sustained positive quarterly FCF generation or a reduction in debt leverage. It would turn bearish if revenue growth decelerates below 15% while FCF remains deeply negative.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Oracle Corporation's 12-month outlook, with a consensus price target around $244.83 and implied upside of +30.0% versus the current price.
Average Target
$244.83
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$151 - $245
Analyst target range
Oracle is covered by 9 analysts, and the institutional ratings show a overwhelmingly bullish consensus, with recent actions from firms like Mizuho, Guggenheim, Citigroup, and JP Morgan (which upgraded from Neutral to Overweight) all maintaining Buy, Outperform, or Overweight ratings. The average estimated EPS for the forward period is $19.65, with a range from $16.41 to $20.71, while the average estimated revenue is $217.88 billion. The lack of a specific consensus price target in the data necessitates calculating implied upside based on earnings estimates, but the uniform bullish sentiment is clear. The wide EPS estimate range, with a high of $20.71 and a low of $16.41, reflects significant uncertainty among analysts regarding the company's near-term profitability amidst its heavy investment cycle. The high target likely assumes successful execution on AI investments leading to margin expansion and accelerated growth, while the low target likely factors in prolonged cash burn, competitive pressures, and potential margin compression. The recent cluster of analyst actions in March 2026 were all reaffirmations or upgrades, indicating sustained institutional support despite the stock's weakness and spending concerns.
Bulls vs Bears: ORCL Investment Factors
The investment debate for Oracle centers on a classic growth-at-a-cost tension. Bullish evidence is anchored in powerful forward-looking indicators: a massive $638B AI backlog, accelerating 21.7% revenue growth, and unanimous analyst bullishness. Bearish evidence focuses on severe present-day financial strain: catastrophic -$24.7B free cash flow, extreme leverage (D/E of 3.63), and significant stock underperformance. Currently, the bear case holds stronger evidence due to the concrete, quantifiable financial deterioration (negative FCF, high debt) that directly impacts shareholder value today. The single most important tension is whether the massive current cash burn and leverage will successfully convert the AI backlog into profitable, high-margin revenue before financial constraints or investor patience run out. The stock's fate hinges on this execution bridge between future promise and present pain.
Bullish
- Massive AI Backlog & Growth: Oracle's massive $638 billion backlog, as highlighted in recent news, signals immense future demand for its AI infrastructure services. This backlog, coupled with Q3 FY2026 revenue growth of 21.66% YoY, provides strong visibility for future top-line expansion.
- Accelerating Cloud Revenue: The company's core Cloud and License segment generated $15.03 billion in Q3 FY2026, driving the overall 21.66% revenue growth. This demonstrates successful execution in transitioning its legacy enterprise base to cloud-based solutions, a critical long-term growth driver.
- Strong Profitability & Margins: Oracle maintains robust profitability with a Q3 net margin of 21.65% and an operating margin of 32.79%. Its trailing Return on Equity (ROE) of 39.69% is exceptionally high, indicating efficient use of shareholder capital, albeit leveraged.
- Analyst Consensus Bullish: All 9 covering analysts maintain Buy-equivalent ratings, with recent actions including an upgrade from JP Morgan. This unanimous institutional support, despite the stock's weakness, underscores confidence in the long-term AI investment thesis.
Bearish
- Severe Negative Free Cash Flow: Oracle's trailing twelve-month free cash flow is deeply negative at -$24.74 billion, a critical red flag. This massive cash burn funds aggressive AI capex, creating near-term financial strain and increasing dependency on external financing.
- Extreme Leverage & High Beta: A debt-to-equity ratio of 3.63 indicates a highly leveraged balance sheet. Combined with a beta of 1.655, the stock is 66% more volatile than the market, amplifying downside risk during market corrections.
- Underperformance & Technical Weakness: The stock has underperformed the S&P 500 by -30.73% over the past year and trades at just 53% of its 52-week range ($134.57 to $345.72). The recent 1-month price change of -2.97% shows the rally from April lows has stalled.
- Earnings & Margin Volatility: Profitability is highly volatile; Q3 net income of $3.72 billion (21.65% margin) fell sharply from Q2's $6.14 billion (38.21% margin). This lumpiness creates uncertainty and makes future earnings difficult to predict.
ORCL Technical Analysis
Oracle's stock is in a pronounced downtrend, with a 1-year price change of -7.87% significantly underperforming the S&P 500's +22.86% gain. The current price of $184.13 sits at just 53% of its 52-week range ($134.57 to $345.72), indicating the stock is trading much closer to its annual lows than its highs, which suggests a value opportunity but also reflects significant negative momentum and investor skepticism. The stock has experienced extreme volatility, with a maximum drawdown of -58.43% and a beta of 1.655, meaning it is approximately 66% more volatile than the broader market, which is critical for risk assessment. Recent momentum shows a sharp divergence; while the 3-month price change is a positive 18.71%, the 1-month change is -2.97%, indicating the recent rally has stalled and reversed. This short-term weakness contrasts with the positive 3-month performance, signaling a potential failure of the recovery attempt or a consolidation phase after the sharp rally from the April lows. The stock's relative strength versus the S&P 500 is negative across all periods, most notably -30.73% over one year, underscoring persistent underperformance. Key technical levels are clearly defined, with immediate support at the 52-week low of $134.57 and major resistance at the 52-week high of $345.72. A sustained breakdown below the $135 level would signal a continuation of the bearish trend, while a move above the recent June high near $248 would be necessary to suggest a more durable recovery is underway. The high beta of 1.655 confirms the stock's elevated volatility, meaning position sizing must account for its amplified swings relative to the market.
Beta
1.66
1.66x market volatility
Max Drawdown
-58.4%
Largest decline past year
52-Week Range
$135-$346
Price range past year
Annual Return
-10.8%
Cumulative gain past year
| Period | ORCL Return | S&P 500 |
|---|---|---|
| 1m | -2.4% | +1.5% |
| 3m | +23.2% | +13.4% |
| 6m | +4.6% | +10.9% |
| 1y | -10.8% | +24.5% |
| ytd | -3.8% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ORCL Fundamental Analysis
Oracle's revenue trajectory shows robust growth, with Q3 FY2026 revenue of $17.19 billion representing a 21.66% year-over-year increase. This growth is accelerating from the prior-year Q3 revenue of $14.13 billion, driven primarily by its Cloud and License business segment, which contributed $15.03 billion in the latest quarter. However, revenue growth has been volatile on a sequential basis, with Q3 revenue up from Q1's $14.93 billion but down from Q2's $16.06 billion, indicating potential lumpiness in contract timing or cloud consumption patterns. The company is profitable, with Q3 net income of $3.72 billion and a net margin of 21.65%. Gross margin for the quarter was 62.16%, while the operating margin was 32.79%. Profitability has fluctuated significantly between quarters; for instance, Q2 net income was $6.14 billion with a net margin of 38.21%, indicating potential one-time benefits or cost timing. The trailing twelve-month free cash flow is deeply negative at -$24.74 billion, a critical red flag signaling massive capital investment is outpacing operating cash generation. Balance sheet health is a concern, with a debt-to-equity ratio of 3.63 indicating a highly leveraged capital structure. The current ratio is 1.12, suggesting adequate but not robust short-term liquidity. Return on equity is very strong at 39.69%, but this is inflated by the high financial leverage. The negative free cash flow of -$24.74 billion highlights that the company is funding its aggressive growth ambitions through external financing rather than internal cash generation, increasing financial risk.
Quarterly Revenue
$17.2B
2026-02
Revenue YoY Growth
+0.21%
YoY Comparison
Gross Margin
+0.62%
Latest Quarter
Free Cash Flow
$-24.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ORCL Overvalued?
Given Oracle's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 41.80x, while the forward PE is significantly lower at 16.94x. This large gap implies the market expects a substantial earnings recovery or growth in the coming year, pricing in an improvement from current depressed profitability levels. Compared to sector averages, Oracle's trailing PE of 41.80x appears elevated, though direct industry average data is not provided in the valuation set. Its Price-to-Sales ratio of 10.60x and EV-to-Sales of 9.71x are also rich multiples that typically command a premium for expected high growth. The PEG ratio of 1.26, based on forward earnings, suggests the stock is fairly valued relative to its expected growth rate, not egregiously overvalued. Historically, Oracle's current trailing PE of 41.80x is above its own recent historical range observed in the data; for example, it was 27.89x at the end of Q3 FY2026 and 23.45x at the end of Q2 FY2026. This indicates the current multiple has expanded despite the stock price decline, because earnings have fallen more sharply. Trading near the higher end of its recent PE band suggests the market is still pricing in a recovery, but leaves little room for error if execution falters.
PE
41.8x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -49x~55x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
26.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on cash burn and leverage. The -$24.74 billion TTM free cash flow indicates Oracle is funding its aggressive AI capex entirely through external financing, not operations. This creates dependency on capital markets and increases financial risk. The debt-to-equity ratio of 3.63 signifies a highly leveraged balance sheet, making the company sensitive to interest rate changes. Furthermore, quarterly net income volatility—ranging from a 38.2% margin in Q2 to 21.7% in Q3—creates earnings uncertainty and complicates forecasting.
Market & Competitive Risks are elevated due to valuation, volatility, and sector dynamics. The stock's high beta of 1.655 means it will likely fall more than the market in a downturn, as evidenced by its -58.43% maximum drawdown. Trading at a trailing P/E of 41.80x, which is above its recent historical range, leaves it vulnerable to multiple compression if growth expectations are not met. Competitive risks are highlighted in recent news discussing pressure from new AI models and the capital-intensive nature of competing with cloud giants like AWS and Azure, which could prolong the cash burn phase.
Worst-Case Scenario involves a failure to convert AI investments into profitable growth before financial strain triggers a crisis. A chain of events could include: 1) slower-than-expected backlog conversion due to execution issues or competitive wins, 2) sustained negative FCF forcing additional debt issuance at higher rates, 3) a quarterly earnings miss triggering analyst downgrades, and 4) a broader market sell-off amplifying the stock's high beta. This could realistically drive the stock back to its 52-week low of $134.57, representing a downside of approximately -27% from the current price of $184.13. A break below this level could signal a deeper crisis of confidence.
FAQ
The key risks are, in order of severity: 1) Financial Risk: Catastrophic negative free cash flow of -$24.74B and high leverage (D/E 3.63) could lead to shareholder dilution or credit rating pressure. 2) Execution Risk: Volatile quarterly earnings (net margin swung from 38.2% to 21.7% between Q2 and Q3) and the challenge of profitably converting the massive AI backlog. 3) Market Risk: A beta of 1.655 means the stock will fall more than the market in a downturn, as seen in its -58.4% max drawdown. 4) Competitive Risk: Intense competition in cloud infrastructure from better-capitalized rivals could pressure margins and prolong the cash burn phase.
The 12-month forecast is highly bifurcated, with a base case target range of $190-$250 (50% probability). This scenario assumes continued ~20% revenue growth but persistent negative free cash flow, leading to range-bound trading. The bull case (25% probability) targets $300-$345, requiring successful AI backlog conversion and a return to positive FCF. The bear case (25% probability) sees a retest of the 52-week low near $135, triggered by execution missteps and sustained cash burn. The most likely outcome is the base case, as it balances the strong growth narrative with the tangible financial headwinds that will take multiple quarters to resolve.
ORCL's valuation presents a mixed picture, leaning towards fair value. The trailing P/E of 41.80x appears elevated and above its recent historical range, suggesting overvaluation based on current earnings. However, the forward P/E of 16.94x implies the market expects a significant earnings recovery, pricing in future growth. The PEG ratio of 1.26, based on forward earnings, is near the benchmark of 1.0, indicating fair valuation relative to expected growth. Therefore, the stock is not egregiously overvalued, but it is also not cheap; it is fairly valued for the growth it is projected to deliver, leaving no margin of safety for execution errors.
ORCL is a high-risk, high-potential reward stock that is a good buy only for a specific investor profile. For aggressive, long-term investors who can tolerate extreme volatility (beta of 1.655) and are confident in Oracle's ability to convert its $638 billion AI backlog into profits, the current price may offer an entry point. The unanimous bullish analyst sentiment and 21.7% revenue growth are compelling. However, for most investors, the severe negative free cash flow (-$24.7B) and high debt (D/E 3.63) present substantial risks, making it a Hold rather than a clear Buy. It becomes a more compelling buy if quarterly free cash flow shows a definitive path to positivity.
ORCL is strictly a long-term investment, with a suggested minimum holding period of 3-5 years. The company's thesis revolves around a multi-year capital investment cycle to build AI infrastructure, meaning the payoff from today's negative free cash flow will not be realized in the short term. The stock's high beta of 1.655 and extreme volatility make it unsuitable for short-term trading, as unpredictable swings can quickly erase gains. Furthermore, the lack of a meaningful dividend (0.81% yield) offers no income cushion for short-term holders. Only investors with a long-time horizon can realistically wait for the growth investments to mature and for financial metrics to improve.
